1,646
Views
40
CrossRef citations to date
0
Altmetric
Non-neutralizing protective antibodies

Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC

, , , , , , & show all
Pages 1-10 | Received 13 Jul 2015, Accepted 12 Nov 2015, Published online: 25 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vo Van Giau, Hyon Lee, Seong Soo A An & John Hulme. (2019) Recent advances in the treatment of C. difficile using biotherapeutic agents. Infection and Drug Resistance 12, pages 1597-1615.
Read now
Séverine Péchiné, Claire Janoir & Anne Collignon. (2017) Emerging monoclonal antibodies against Clostridium difficile infection. Expert Opinion on Biological Therapy 17:4, pages 415-427.
Read now

Articles from other publishers (38)

Jean-Christophe Marvaud, Sylvie Bouttier, Johanna Saunier & Imad Kansau. (2024) Clostridioides difficile Flagella. International Journal of Molecular Sciences 25:4, pages 2202.
Crossref
Camille Campidelli, Jean-François Bruxelle, Anne Collignon & Severine Péchiné. 2024. Updates on Clostridioides difficile in Europe. Updates on Clostridioides difficile in Europe 117 150 .
Md Zahidul Alam, John E. Markantonis & John T. Fallon. (2023) Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches. Tropical Medicine and Infectious Disease 8:12, pages 506.
Crossref
Farha Naz & William A. Petri. (2023) Host Immunity and Immunization Strategies for Clostridioides difficile Infection. Clinical Microbiology Reviews 36:2.
Crossref
Joshua Heuler, Harish Chandra & Xingmin Sun. (2023) Mucosal Vaccination Strategies against Clostridioides difficile Infection. Vaccines 11:5, pages 887.
Crossref
Shaohui Wang, Xianghong Ju, Joshua Heuler, Keshan Zhang, Zhibian Duan, Hiran Malinda Lamabadu Warnakulasuriya Patabendige, Song Zhao & Xingmin Sun. (2023) Recombinant Fusion Protein Vaccine Containing Clostridioides difficile FliC and FliD Protects Mice against C. difficile Infection. Infection and Immunity 91:4.
Crossref
Jeffrey K. J. Cheng & Meera Unnikrishnan. (2023) Clostridioides difficile infection: traversing host–pathogen interactions in the gut. Microbiology 169:2.
Crossref
Frederick Odun-Ayo & Lalini Reddy. (2023) Potential Biomedical Applications of Modified Pectin as a Delivery System for Bioactive Substances. Polysaccharides 4:1, pages 1-32.
Crossref
A.R. Valipouri, S. Rahimi, A.A. Karkhane, M.A. Karimi Torshizi, A.M. Mobarez & J.L. Grimes. (2022) Immunization of broiler chickens with recombinant alpha-toxin protein for protection against necrotic enteritis. Journal of Applied Poultry Research 31:4, pages 100299.
Crossref
Caixia Tan, Fei Zhu, Yuanyuan Xiao, Yuqi Wu, Xiujuan Meng, Sidi Liu, Ting Liu, Siyao Chen, Juan Zhou, Chunhui Li & Anhua Wu. (2022) Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile. Frontiers in Immunology 13.
Crossref
Jaime Hughes, Carl Aston, Michelle L. Kelly & Ruth Griffin. (2022) Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile. Pharmaceutics 14:5, pages 1086.
Crossref
Natalie S. Haddad, Sophia Nozick, Geena Kim, Shant Ohanian, Colleen S. Kraft, Paulina A. Rebolledo, Yun Wang, Hao Wu, Adam Bressler, Sang Nguyet Thi Le, Merin Kuruvilla, Martin C. Runnstrom, Richard P. Ramonell, L. Edward Cannon, F. Eun-Hyung Lee & John L. Daiss. (2022) Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection. Journal of Clinical Microbiology 60:3.
Crossref
Narjes Noori Goodarzi, Sepideh Fereshteh, Omid Azizi, Hamzeh Rahimi, Negin Bolourchi & Farzad Badmasti. (2022) Subtractive genomic approach toward introduction of novel immunogenic targets against Clostridioides difficile: Thinking out of the box. Microbial Pathogenesis 162, pages 105372.
Crossref
Britt Nibbering, Dale N. Gerding, Ed J. Kuijper, Romy D. Zwittink & Wiep Klaas Smits. (2021) Host Immune Responses to Clostridioides difficile: Toxins and Beyond. Frontiers in Microbiology 12.
Crossref
Srijita Basak, Debashrito Deb, Utkarsh Narsaria, Tamalika Kar, Filippo Castiglione, Indraneel Sanyal, Pratap D. Bade & Anurag P. Srivastava. (2021) In silico designing of vaccine candidate against Clostridium difficile. Scientific Reports 11:1.
Crossref
A. Razim, K. Pacyga, P. Naporowski, D. Martynowski, A. Szuba, A. Gamian & S. Górska. (2021) Identification of linear epitopes on the flagellar proteins of Clostridioides difficile. Scientific Reports 11:1.
Crossref
Natalie S. Haddad, Sophia Nozick, Geena Kim, Shant Ohanian, Colleen Kraft, Paulina A. Rebolledo, Yun Wang, Hao Wu, Adam Bressler, Sang Nguyet Thi Le, Merin Kuruvilla, L. Edward Cannon, F. Eun-Hyung Lee & John L. Daiss. (2021) Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA). Journal of Immunological Methods 492, pages 112932.
Crossref
Hannah D. Steinberg & Evan S. Snitkin. (2020) Homologous Recombination in Clostridioides difficile Mediates Diversification of Cell Surface Features and Transport Systems . mSphere 5:6.
Crossref
Dominika Trzilova, Brandon R. Anjuwon-Foster, Dariana Torres Rivera & Rita Tamayo. (2020) Rho factor mediates flagellum and toxin phase variation and impacts virulence in Clostridioides difficile. PLOS Pathogens 16:8, pages e1008708.
Crossref
Zhipeng Xu, Minjun Ji, Chen Li, Xiaofeng Du, Wei Hu, Donald Peter McManus & Hong You. (2020) A Biological and Immunological Characterization of Schistosoma Japonicum Heat Shock Proteins 40 and 90α. International Journal of Molecular Sciences 21:11, pages 4034.
Crossref
T.V. Riley, D. Lyras & G.R. Douce. (2019) Status of vaccine research and development for Clostridium difficile. Vaccine 37:50, pages 7300-7306.
Crossref
Xiaohui Ma, Caidie Wang, Baojiang Zhang, Lining Xia & Yan Su. (2019) Antibody kinetics and immune profile analysis of a Streptococcus equi DNA vaccine expressing the FljB and SeM fusion protein in murine and equine models. Research in Veterinary Science 125, pages 82-88.
Crossref
Jhansi L. Leslie, Kimberly C. Vendrov, Matthew L. Jenior & Vincent B. Young. (2019) The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity. mSphere 4:1.
Crossref
Amber Howerton, Cale O. Seymour, Senthil K. Murugapiran, Zhenlin Liao, Jacqueline R. Phan, Alan Estrada, Adam J. Wagner, Chrisabelle C. Mefferd, Brian P. Hedlund & Ernesto Abel-Santos. (2018) Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
J.F. Bruxelle, N. Tsapis, S. Hoys, A. Collignon, C. Janoir, E. Fattal & S. Péchiné. (2018) Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads. Vaccine 36:40, pages 6017-6021.
Crossref
Brandon R. Anjuwon-Foster, Natalia Maldonado-Vazquez & Rita Tamayo. (2018) Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates. Journal of Bacteriology 200:14.
Crossref
Séverine Péchiné, Jean F. Bruxelle, Claire Janoir & Anne Collignon. (2018) Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection. Frontiers in Microbiology 9.
Crossref
Monique J. T. Crobach, Jonathan J. Vernon, Vivian G. Loo, Ling Yuan Kong, Séverine Péchiné, Mark H. Wilcox & Ed J. Kuijper. (2018) Understanding Clostridium difficile Colonization. Clinical Microbiology Reviews 31:2.
Crossref
Kathryn L. Nawrocki, Daniela Wetzel, Joshua B. Jones, Emily C. Woods & Shonna M. McBride. (2018) Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis . Environmental Microbiology 20:4, pages 1419-1435.
Crossref
William D. Rees & Theodore S. Steiner. (2018) Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy . European Journal of Immunology 48:3, pages 398-406.
Crossref
Jean-François Bruxelle, Séverine Péchiné & Anne Collignon. 2018. Updates on Clostridium difficile in Europe. Updates on Clostridium difficile in Europe 197 225 .
Jean-François Bruxelle, Assaf Mizrahi, Sandra Hoÿs, Anne Collignon, Claire Janoir & Séverine Péchiné. (2017) Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile. PLOS ONE 12:11, pages e0187212.
Crossref
Silvia Beurmann, Blake Ushijima, Patrick Videau, Christina Marie Svoboda, Ashley Marie Smith, Orion Silverstar Rivers, Greta Smith Aeby & Sean Michael Callahan. (2017) Pseudoalteromonas piratica strain OCN003 is a coral pathogen that causes a switch from chronic to acute Montipora white syndrome in Montipora capitata. PLOS ONE 12:11, pages e0188319.
Crossref
Brandon R. Anjuwon-Foster & Rita Tamayo. (2017) A genetic switch controls the production of flagella and toxins in Clostridium difficile. PLOS Genetics 13:3, pages e1006701.
Crossref
Chad K. Porter, Tia Sorrell, Indrani Mitra & Mark S. Riddle. (2017) Vaccination of active component US military personnel against Salmonella Typhi. Vaccine 35:14, pages 1742-1748.
Crossref
Esmeralda Valiente, Laura Bouché, Paul Hitchen, Alexandra Faulds-Pain, Mario Songane, Lisa F. Dawson, Elizabeth Donahue, Richard A. Stabler, Maria Panico, Howard R. Morris, Mona Bajaj-Elliott, Susan M. Logan, Anne Dell & Brendan W. Wren. (2016) Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation. Journal of Biological Chemistry 291:49, pages 25450-25461.
Crossref
Mathias W. Pletz, Julia Uebele, Karen Götz, Stefan Hagel & Isabelle Bekeredjian-Ding. (2016) Vaccines against major ICU pathogens: where do we stand?. Current Opinion in Critical Care 22:5, pages 470-476.
Crossref
Joshua M. A. Stough, Stephen P. Dearth, Joshua E. Denny, Gary R. LeCleir, Nathan W. Schmidt, Shawn R. Campagna & Steven W. Wilhelm. (2016) Functional Characteristics of the Gut Microbiome in C57BL/6 Mice Differentially Susceptible to Plasmodium yoelii. Frontiers in Microbiology 7.
Crossref